Pluristem Therapeutics Inc (PSTI)

[thesaud]

there won't be to much upswing until 2nd half of 2017, once they get those phase 3 trials going and report interim results, that's when we will see up swing, but when it does start moving it could move up fast to $5.00. We are undervalued at this point, and the street has not seen the great potential here. go to yahoo psti and read all the articles in the last 6 months you will feel a lot better about your investment in psti. The sinofi, psti article is very interesting, where sinofi failed in its p3 for cli psti will succeed, thats why the EMA is throwing $9,000,000 to fund the trial in Europe where Germany has the most cli patients in Europe, they picked psti and 5 other companies for their horizens project pathway to approvel. they since have closed it. the EMA and Japan want psti to succeed very badly. I'm holding out hope they will have some kind of conditional approvel by this time next year, or sooner. this is a huge trial or trials for psti. imagine they could have the cli, pad, and ic market all wrapped up no competition, not to mention all of the other indies. cell based therepy is coming on fast and it will be the next big thing in therapeutic medicine